Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”

키워드

참고문헌 (6)

1. 김수진, "Evidence Is Enough?: A Systematic Review and Network Meta- Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients", International Neurourology Journal, 21(1), pp.29~37 (2017), 대한배뇨장애요실금학회
2. Efficacy of dose escalation of tamsulosin for the treatment in symptomatic benign prostatic hyperplasia of lower urinary tract symptom: a randomised, double-blind, phase 3 trial in Korean Men, "Kim KS", American Urological Association, ~ (2016)
3. Choi H, "Assessment of tamsulosin 0.2 mg for symptomatic bladder outlet obstruction secondary to benign prostatic enlargement: data from a Korean multicenter cross-sectional study", Urol Int, 95, pp.50~55 (2015)
4. Kim JW, "Efficacy of Dose Escalation of tamsulosin for the treatment of lower urinary tract symptoms", Low Urin Tract Symptoms, 4, pp.96~102 (2012)
5. NCD Risk Factor Collaboration (NCD-RisC), "A century of trends in adult human height", Elife, 5, pp.e13410~ (2016)
6. Kawabe K, "Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group", J Urol, 144, pp.908~911 (1990)

관련 논문AI추천